United Therapeutics Corp. (UTHR)
473.42
-7.10
(-1.48%)
USD |
NASDAQ |
Feb 20, 16:00
472.79
-0.63
(-0.13%)
After-Hours: 20:00
United Therapeutics Market Cap : 20.38B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.663B |
| Catalyst Pharmaceuticals, Inc. | 2.987B |
| MannKind Corp. | 1.701B |
| Madrigal Pharmaceuticals, Inc. | 9.880B |
| Vertex Pharmaceuticals, Inc. | 121.15B |
Market Cap Related Metrics
| PE Ratio | 17.94 |
| PS Ratio | 7.298 |
| PEG Ratio | 1.13 |
| Price to Book Value | 3.093 |
| Price to Free Cash Flow | 20.45 |
| Price | 473.42 |
| Earnings Yield | 5.57% |
| PEGY Ratio | 1.13 |
| Operating PE Ratio | 15.06 |
| Normalized PE Ratio | 17.74 |